Brief: Lineage Cell Therapeutics Receives CE Mark Approval For Renevia

Lineage Cell Therapeutics

19/09/2019 12:09

Sept 19 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE CELL THERAPEUTICS RECEIVES CE MARK APPROVAL FOR
RENEVIA®
    * LINEAGE CELL THERAPEUTICS INC - TRIAL MET ITS PRIMARY
ENDPOINT
OF CHANGE IN HEMIFACIAL VOLUME AT SIX MONTHS
    * LINEAGE CELL THERAPEUTICS - BELIEVE IT IS IN BEST
INTERESTS OF
SHAREHOLDERS TO SEEK EXTERNAL PARTNER TO LAUNCH RENEVIA IN
EUROPEAN MARKET

Source text for Eikon:  ID:nBw1ld8j6a 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))